2016
DOI: 10.1148/radiol.2016140049
|View full text |Cite
|
Sign up to set email alerts
|

Multimodality Molecular Imaging of Cardiac Cell Transplantation: Part I. Reporter Gene Design, Characterization, and Optical in Vivo Imaging of Bone Marrow Stromal Cells after Myocardial Infarction

Abstract: 4 The complete list of authors is at the end of this article.q RSNA, 2016 Purpose:To use multimodality reporter-gene imaging to assess the serial survival of marrow stromal cells (MSC) after therapy for myocardial infarction (MI) and to determine if the requisite preclinical imaging end point was met prior to a follow-up large-animal MSC imaging study. Materials and Methods:Animal studies were approved by the Institutional Administrative Panel on Laboratory Animal Care. Mice (n = 19) that had experienced MI… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
11
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
4
1
1

Relationship

2
4

Authors

Journals

citations
Cited by 14 publications
(11 citation statements)
references
References 39 publications
0
11
0
Order By: Relevance
“…HepG2 cells (p10) cultivated at 200,000 cells/well in a 6-well plate, were transfected with a third generation lentivirus bearing a transgene (ubiquitin-fluc2-egfp (Human Ubiquitin promoter, Firefly luciferase 2, enhanced green fluorescent protein)), as done previously, (Parashurama, Ahn et al 2016) at an MOI of 5.…”
Section: Engineering a Stable Gfp/firefly Luciferase Hepg2 Cell Linementioning
confidence: 99%
“…HepG2 cells (p10) cultivated at 200,000 cells/well in a 6-well plate, were transfected with a third generation lentivirus bearing a transgene (ubiquitin-fluc2-egfp (Human Ubiquitin promoter, Firefly luciferase 2, enhanced green fluorescent protein)), as done previously, (Parashurama, Ahn et al 2016) at an MOI of 5.…”
Section: Engineering a Stable Gfp/firefly Luciferase Hepg2 Cell Linementioning
confidence: 99%
“…For in vivo imaging with BLI, a substrate is required that has to be stable, bioavailable, have favorable pharmacokinetics. Fluc has been used for a wide range of cell imaging applications, including neural stem cell tracking in the brain, cardiac cell transplantation, assessment of gene delivery, epigenetic modulation of reporter expression, immunosuppression efficacy, graft versus host disease, evaluation of tissue scaffolds, whole body HSC reconstitution liver cell therapy, encapsulated in vivo cell viability, decellularized liver matrix, oxidative stress within transplanted cells, differentiation, and multimodality imaging . This information is summarized in Figure and Table .…”
Section: Cell Imaging With Reporter Genesmentioning
confidence: 99%
“…Dosing with pharmaceutical can be done based on mass of the patient (or the amount of receptor available), but because molecular targets of cell therapies are complex, it is unclear how to perform exact dosing. In a recent set of publications, we demonstrated experimentally an idea of how molecular imaging in small animals and large animals could be connected, to improve the clinical translation of cell therapies . In this case, multimodality RG, bearing eGFP (enhanced GFP), Fluc2, and hsv1 mutant (sr39tk), for fluorescence, bioluminescence, and PET RG imaging, were transduced into MSC.…”
Section: “Next Generation” Regenerative Medicinementioning
confidence: 99%
See 2 more Smart Citations